Loading stock data…
CHF 122.18+2.88 (+2.41%)
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Novartis AG in the Healthcare sector is trading at $122.18 with a market capitalization of $232.7B. Wall Street consensus targets $125.85 (22 analysts), implying a +3.0% move over the next 12 months. The stock is currently 8% below its 52-week high of $132.68, remaining 2.1% above its 200-day moving average. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | $14.84B↑ | $14.36B↑ | $13.86B↑ | $13.52B↓ | $14.95B |
| Gross Profit | $11.51B↑ | $10.82B↑ | $10.25B↑ | $10.06B↓ | $11.24B |
| Operating Income | $4.86B↑ | $4.50B↑ | $3.62B↓ | $4.24B↓ | $4.75B |
| Net Income | $4.04B↑ | $3.93B↑ | $2.41B↓ | $3.16B↓ | $3.26B |
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart f...